Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing (September 2020) | Zendy

Kimberly E. Hanson | Zendy; Angela M. Caliendo | Zendy; Cesar Andres Diaz Arias | Zendy; Janet A. Englund | Zendy; Mary K. Hayden | Zendy; Mark J. Lee | Zendy; Mark Loeb | Zendy; Robin Patel | Zendy; Osama Altayar | Zendy; Abdallah El Alayli | Zendy; Shahnaz Sultan | Zendy; Yngve FalckYtter | Zendy; Valéry Lavergne | Zendy; Rebecca L. Morgan | Zendy; M. Hassan Murad | Zendy; Adarsh Bhimraj | Zendy; Reem A. Mustafa | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing (September 2020)

Author(s) -

Kimberly E. Hanson,

Angela M. Caliendo,

Cesar Andres Diaz Arias,

Janet A. Englund,

Mary K. Hayden,

Mark J. Lee,

Mark Loeb,

Robin Patel,

Osama Altayar,

Abdallah El Alayli,

Shahnaz Sultan,

Yngve FalckYtter,

Valéry Lavergne,

Rebecca L. Morgan,

M. Hassan Murad,

Adarsh Bhimraj,

Reem A. Mustafa

Publication year - 2020

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciaa1343

Subject(s) - covid-19 , serology , virology , coronavirus , medicine , pandemic , infectious disease (medical specialty) , disease , coronavirus infections , betacoronavirus , immunology , outbreak , antibody , pathology

The availability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serologic testing has rapidly increased. Current assays use a variety of technologies, measure different classes of immunoglobulin or immunoglobulin combinations and detect antibodies directed against different portions of the virus. The overall accuracy of these tests, however, has not been well-defined. The Infectious Diseases Society of America (IDSA) convened an expert panel to perform a systematic review of the coronavirus disease 2019 (COVID-19) serology literature and construct best practice guidance related to SARS-CoV-2 serologic testing. This guideline is the fourth in a series of rapid, frequently updated COVID-19 guidelines developed by IDSA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research